Physician

Alexander Herbst, MD

According to 2025 Medicare claims, Alexander Herbst, MD (NPI: 1437680949) practices dermatology in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is JAY S. HERBST M.D., P.A. (NPI: 1033488424; TIN: 650384510) and primary practice location at 33952-5126.

Herbst's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,115 traditional Medicare patients, billed 10,905 HCPCS/CPT codes, and received $777,317 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 891 prescription claims across 422 beneficiaries totaling $337,990 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 24 records totaling $610. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $209 to $337,990. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$389K$777K2021 Medicare payment: $176,361 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $561,294 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $772,879 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $777,317 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213574,696$176,361
20226369,217$561,294
202394811,125$772,879
20241,11510,905$777,317

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$169K$338K2017 Drug cost: $209 (USD; Tot_Drug_Cst)2018 Drug cost: $28,801 (USD; Tot_Drug_Cst)2019 Drug cost: $12,718 (USD; Tot_Drug_Cst)2020 Drug cost: $28,983 (USD; Tot_Drug_Cst)2021 Drug cost: $7,258 (USD; Tot_Drug_Cst)2022 Drug cost: $67,419 (USD; Tot_Drug_Cst)2023 Drug cost: $176,035 (USD; Tot_Drug_Cst)2024 Drug cost: $337,990 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R30$209
20182245$28,801
201932108$12,718
2020N/R15$28,983
2021101169$7,258
2022231548$67,419
2023353726$176,035
2024422891$337,990

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks292393$513
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more562905$68
11102Biopsy of related skin growth, first growth351466$65
17000Destruction of precancer skin growth, 1 growth404606$35
17003Destruction of precancer skin growth, 2-14 growths3312,125$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab24658$95,631
Clobetasol PropionateClobetasol Propionate601,832$2,427
KetoconazoleKetoconazole952,969$1,731
Gentamicin SulfateGentamicin Sulfate31819$1,158
FluorouracilFluorouracil13332$915

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$610Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander Herbst, MD?

Tedicare shows public-source Medicare data for Alexander Herbst, MD (NPI 1437680949), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Herbst, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Herbst, MD?

Alexander Herbst, MD is linked to JAY S. HERBST M.D., P.A. (billing NPI 1033488424) in the available physician profile data.

Does Alexander Herbst, MD have Open Payments data?

Alexander Herbst, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.